Organization · Venture Capital
BEAST
BEAST is a London-based venture capital firm that invests in breakthrough engineering, applied science, and technology startups across the UK and Continental Europe, focusing on Seed Stage companies.
Overview
What BEAST does
What BEAST is
BEAST is a London-based venture capital firm that invests in breakthrough engineering, applied science, and technology startups across the UK and Continental Europe, focusing on Seed Stage companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 22, 2026
Official channels
Find BEAST elsewhere
Open the official website or a supported primary organization account.
Capability profile
BEAST as a funder
Investment thesis
BEAST focuses on investing in deep tech and frontier science startups at the Seed Stage, particularly those with potential health, climate, or societal impacts.
Focus narrative
BEAST invests primarily in startups engaged in breakthrough engineering and applied science across various sectors. The firm is particularly interested in deep technologies that can address pressing health, climate, and societal issues. Its investment strategy is centered on Seed Stage companies located in the UK and Continental Europe, aiming to foster innovation that leads to impactful solutions.
Value beyond capital
BEAST provides significant value-add to its portfolio companies by offering strategic guidance, industry connections, and support throughout their growth journey. The firm emphasizes a hands-on approach, leveraging its expertise in breakthrough engineering and applied science to help startups navigate challenges and scale effectively.
Terms and economics
- Typical check
- $2,600,000
- Sweet spot
- $2,600,000
Focus and fit
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 38
- Recorded notable exits
- Sonalytic
Portfolio context
Q Bio: Technology for early disease detection using machine learning. TRACE GENOMICS: Analytics engine for maximizing soil value. Sparrho: AI-driven tailored science news. Inoviv: Biomarker tests for novel therapies. Ochre Bio: Genomic medicines for liver transplants. LABGENIUS: Protein-based therapeutics using machine learning. PERCEPTO: Computer vision for autonomous drones in renewable energy. FaceSoft: Deep learning for facial analysis. Helix Nano: mRNA therapeutics for diseases. Nutropy: Environmentally friendly cheese production. Baseimmune: Broad-spectrum vaccines. Sonalytic: Music identification using machine learning. Scantrust: B2B SaaS for supply chain traceability. Cogitat: AI for brain-computer interfaces. HIGHER STEAKS: Lab-grown meat products. LYDIA.AI: AI for healthcare optimization. Senzo: Diagnostic products for point of care.
Common questions
What to know about BEAST
Upseed classifies BEAST under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 22, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.